Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) typically begins acting within the first week of your first injection, though most people notice meaningful appetite changes between weeks two and four. Measurable weight loss usually becomes visible after four to eight weeks. You've taken the first dose, the pen is back in the fridge, and now you're waiting — wondering whether anything is actually happening. That uncertainty is one of the most common things people describe in the early weeks of treatment. The honest answer is that tirzepatide is working in your body before you can feel it: the medicine binds to GIP and GLP-1 receptors almost immediately after each injection, slowing gastric emptying and adjusting hunger signals. The question is when those changes translate into something you notice on the scales or at the table. As a prescription-only medicine, Mounjaro is assessed and prescribed individually; your timeline will depend on your starting point, the dose your prescriber has approved, and how your body responds. You can explore what tirzepatide is and how it works in more detail on our Mounjaro overview page.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You've done the injection, disposed of the needle safely, and feel... roughly the same. That's normal. Tirzepatide reaches peak blood concentration roughly 24 to 48 hours after a subcutaneous injection, but the downstream effects (slowed digestion, reduced appetite signalling) take a few days to establish themselves. Some people notice mild nausea or a slight feeling of fullness from day two or three onwards. Others notice nothing at all during the first week.
What's already changed is the rate at which food leaves your stomach. Mounjaro slows gastric emptying, which means your next meal may feel more filling than usual even if the appetite-dampening signal hasn't fully landed yet. Don't read week one as a verdict. The medicine is doing its early work quietly. The full picture of how long Mounjaro takes to work unfolds over a longer arc than a single dose can show.
Side effects, if they arrive, tend to peak in the first two weeks at each dose level and settle as your system adapts. Mild nausea, some loose stools, or reduced appetite for particular foods are the most frequently reported early signs that something is shifting. They are also your first signal that the medicine is active. The NHS tirzepatide patient guide lists the full side-effect profile in plain language.
This is the window most people describe as the first real turning point. The stomach-emptying effect has been consistent across several doses now, and the GLP-1 and GIP receptor activity is starting to shift how hungry you feel between meals. Many people report that a portion they would previously have finished easily becomes more than enough, or that a mid-afternoon snack simply stops feeling necessary.
Scale movement at this stage can be modest, half a kilogram to a couple of kilograms is typical, and some of that is water, not fat. Expect the early weeks to feel underwhelming compared with the longer trajectory. That matters, because the starter dose (2.5 mg) is specifically designed to minimise side effects rather than to drive weight loss. Real therapeutic momentum builds as the dose is increased. If you're curious about how costs change across the dose schedule, the Mounjaro cost page sets out the UK private pricing picture honestly.
Drinking plenty of water, maintaining regular protein intake, and continuing whatever movement you can manage will all support what the medicine is initiating. Your prescriber is the right person to talk to if you're not sure whether what you're experiencing is within the normal range.
Once the dose begins to increase (typically in four-week steps under prescriber guidance) the effects compound. Hunger reduces more substantially, portion sizes fall further, and consistent weight loss becomes measurable. This is the phase that clinical evidence describes most clearly. In SURMOUNT-1, a large phase-3 trial published in the New England Journal of Medicine, adults taking tirzepatide 15 mg lost an average of around 20 to 21% of their body weight over 72 weeks. That reduction didn't happen in the first month; it accumulated across the full trial period, with loss continuing well beyond the six-month point.
How quickly tirzepatide starts working for any individual depends on several factors: starting BMI, metabolic health, consistency of injections, dietary pattern alongside treatment, and which dose the prescriber has approved. There is no universal six-week guarantee. What the trial data do confirm is that results are durable and progressive when treatment continues at an effective dose. For those thinking about whether specific conditions such as lipoedema affect outcomes, that's a useful area to explore separately.
If you've been on Mounjaro for several months and feel progress has stalled, the right step is to speak to your prescriber, not to increase the dose independently. A review of your dose, your injection technique, and any lifestyle factors will give a clearer picture than waiting it out.
Some people feel the appetite effect clearly within ten days. Others reach their first dose increase before anything obvious changes on the scales. Neither is a sign the medicine isn't working; individual response to GLP-1 and GIP receptor agonism varies, and starting dose is a deliberate floor, not the ceiling. A question our prescribers hear regularly is whether a slow first month means failure. It rarely does. The evidence from thousands of adults across the SURMOUNT programme is that results accumulate over months, not days.
If you're wondering how the tirzepatide timeline compares across different starting situations, or want to understand more about what the early weeks look like at the 2.5 mg dose specifically, those pages go into further detail. And if you're weighing up your options more broadly, the weight-loss treatments overview is a good place to see the full picture. When you're ready to take the next step, speak to our prescribers through a free consultation, a GPhC-registered Independent Prescriber, not a chatbot, reviews your answers and advises on suitability the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.